BRIXADI

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 58284-232
  • Package NDC 58284-232-01
  • Application number NDA210136
  • SPL ID 4e1985eb-1302-42e0-ac79-10b0a492966a
  • SPL set ID 5d8a8fd0-8619-422a-a664-d1d2e8970f48
  • UNII 40D3SCR4GZ
  • RxCUI 2639021
  • RxCUI 2639027
  • RxCUI 2639029
  • RxCUI 2639030
  • RxCUI 2639031
  • RxCUI 2639032
  • RxCUI 2639033
  • RxCUI 2639034
  • RxCUI 2639036
  • RxCUI 2639039
  • RxCUI 2639041
  • RxCUI 2639042
  • RxCUI 2639043
  • RxCUI 2639044

What the source publishes

Labeler
Braeburn Inc.
Active ingredients
BUPRENORPHINE
Form
INJECTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:58284-232_4e1985eb-1302-42e0-ac79-10b0a492966a
{
  "name": "BRIXADI",
  "splId": "4e1985eb-1302-42e0-ac79-10b0a492966a",
  "labels": [
    {
      "setId": "5d8a8fd0-8619-422a-a664-d1d2e8970f48",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d8a8fd0-8619-422a-a664-d1d2e8970f48",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d8a8fd0-8619-422a-a664-d1d2e8970f48"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Braeburn Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE, GLASS in 1 CARTON (58284-232-01)  / .64 mL in 1 SYRINGE, GLASS",
      "package_ndc": "58284-232-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230606"
    }
  ],
  "productId": "58284-232_4e1985eb-1302-42e0-ac79-10b0a492966a",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "58284-232",
  "deaSchedule": "CIII",
  "genericName": "BUPRENORPHINE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BUPRENORPHINE",
      "strength": "32 mg/.64mL"
    }
  ],
  "applicationNumber": "NDA210136",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230606",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175689",
      "N0000175685"
    ],
    "unii": [
      "40D3SCR4GZ"
    ],
    "rxcui": [
      "2639021",
      "2639027",
      "2639029",
      "2639030",
      "2639031",
      "2639032",
      "2639033",
      "2639034",
      "2639036",
      "2639039",
      "2639041",
      "2639042",
      "2639043",
      "2639044"
    ],
    "spl_set_id": [
      "5d8a8fd0-8619-422a-a664-d1d2e8970f48"
    ],
    "pharm_class_epc": [
      "Partial Opioid Agonist [EPC]"
    ],
    "pharm_class_moa": [
      "Partial Opioid Agonists [MoA]"
    ],
    "manufacturer_name": [
      "Braeburn Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:58284-232_4e1985eb-1302-42e0-ac79-10b0a492966a"